News
Promising efficacy data with median PFS of 7.2 months (95%CI 5.6-9.2), median OS of 13.7 months (95%CI 11.1-18.3), and 1-year survival of 54% Strong efficacy signal observed in non-squamous ...
3d
News-Medical.Net on MSNEAGLE model predicts key lung cancer mutations from routine biopsyWith EAGLE, lung cancer biopsy analysis is expedited, accurately predicting EGFR mutations and streamlining the diagnostic process for better patient outcomes.
6d
Everyday Health on MSNWhat Is Lung Cancer Surgery?Lung cancer surgery is the primary treatment for lung cancer, when possible. Learn about the multiple types of lung cancer surgery, procedures, and associated risks.
New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for ...
5d
Daily Express US on MSNThe alarming rise in lung cancer in non-smokers and why, according to expertsLung cancer isn't just a smoker's disease. Discover the surprising truth about who else is at risk and why the numbers are rising in unexpected groups.
Your healthcare provider may also recommend a TB test — either a blood test or a skin test. For the skin test, you will need ...
Even a little movement goes a long way. As Dr. George explains, just 75 minutes of activity a week, that’s about 11 minutes a ...
Soft tissue sarcomas are a rare and often under-recognised group of cancers that develop in the connective tissues of the ...
Analysts now project the global oncology drug market could surpass US$900 billion in revenue by 2034. Precedence Research ...
Most of us want to live as long as we can, so we hope for a lengthy lifespan. Age is just a number — we live for a specific ...
Moleculin Biotech, Inc. 40+ year career at Roche founded on dedication to bringing new innovative medicines to patients and ...
Dr Matthew Wheater examines liver-directed therapies for metastatic uveal melanoma and key findings from the pivotal FOCUS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results